07:28 AM EST, 11/04/2025 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) reported a Q3 net loss Tuesday of $0.82 per diluted share, wider than a loss of $0.73 a year earlier.

Four analysts surveyed by FactSet expected a loss of $0.66.

Revenue for the quarter ended Sept. 30 was $51.3 million, up from $33.3 million a year earlier.

Analysts surveyed by FactSet expected $50.7 million.